Arcadia Biosciences, Inc. (RKDA) Stock Score, Valuation & Financial Research
Arcadia Biosciences, Inc. is in the Basic Materials sector and Agricultural Inputs industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 29/100.
Quick answer for RKDA
Arcadia Biosciences, Inc. currently has a Wall Street Score of 29/100. The stored market price is $0.43. Its financial score is 28/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Arcadia Biosciences, Inc. does
Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.
RKDA financial snapshot
- Wall Street Score:
- 29/100
- Current price:
- $0.43
- Market capitalization:
- $667K
- Revenue:
- $4.8M
- Net income:
- $-9.3M
- Free cash flow:
- $-4.7M
- Cash:
- $954K
- Total debt:
- $0
- EPS:
- -1.71
- Financial score:
- 28/100
- Valuation score:
- 0/100
- Revenue score:
- 24/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $-4.7M, showing cash burn in the current stored period.
- The balance sheet shows $954K of cash versus $0 of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 28/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research RKDA
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.